Researchers hope that a test of breath-based biomarkers can help them detect mesothelioma in its early stages. Louisville residents should know that historically, the U.S. has been lagging behind Europe in the use of breath tests to identify cancer. In 2017, a study...
Month: June 2019
Defactinib ineffective for malignant pleural mesothelioma
A COMMAND Phase 2 trial of maintenance therapy using the drug defactinib has been found unable to increase the survival rate of patients with malignant pleural mesothelioma. This aggressive and incurable cancer has few treatment options to begin with; Louisville...
A swallowing problem may indicate mesothelioma
A Kentucky resident experiencing problems swallowing may have an early sign indicating a cancer diagnosis of mesothelioma. Known as dysphagia, this type of symptom involving swallowing difficulties is not usually associated with asbestos-related illnesses. However, a...
Systemic inflammation shortens lives of mesothelioma patients
Mesothelioma, as Louisville residents may know, is an aggressive cancer usually caused by long-term exposure to asbestos. Among mesothelioma patients, there are several factors that can determine how long they have to live, and Chinese researchers have recently...